| 1. | | Recruiting | Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols
Condition: Central Nervous System Neoplasms |
| 2. | | Recruiting | Natural History of Patients with Brain and Spinal Cord Tumors
Conditions: Astrocytoma; Central Nervous System Tumor; Glioblastoma; Glioma; Medulloblastoma |
| 3. | | Not yet recruiting | Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: adult anaplastic oligodendroglioma; adult anaplastic astrocytoma; adult giant cell glioblastoma; adult gliosarcoma; recurrent adult brain tumor |
| 4. | | Recruiting | Interleukin-13 PE38QQR Immunotoxin Compared With Carmustine Implant in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 5. | | Recruiting | An Immunotherapy Vaccine Against Grade IV Brain Tumors
Condition: Brain Neoplasms |
| 6. | | Recruiting | Human Corticotropin-Releasing Factor (hCRF) for Patients Requiring Chronic High-Doses of Dexamethasone to Treat Edema Associated with Malignant Brain Tumors
Conditions: Brain Edema; Brain Tumor |
| 7. | | Recruiting | Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme
Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 8. | | Recruiting | Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
Conditions: adult anaplastic oligodendroglioma; recurrent adult brain tumor; adult glioblastoma; adult anaplastic astrocytoma; adult giant cell glioblastoma; ... |
| 9. | | Recruiting | Erlotinib Compared With Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 10. | | Recruiting | Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
Conditions: adult glioblastoma; recurrent prostate cancer; recurrent adult brain tumor; stage IV prostate cancer; adult giant cell glioblastoma; ... |
| 11. | | Recruiting | FR901228 in Treating Patients With Progressive High-Grade Glioma
Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; adult meningeal tumors; Mixed Gliomas |
| 12. | | Recruiting | AEE788 in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 13. | | Recruiting | Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplantation in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Conditions: childhood brain tumor; childhood rhabdoid tumor of the central nervous system; Neuroblastoma |
| 14. | | Not yet recruiting | Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
Condition: childhood central nervous system germ cell tumor |
| 15. | | Recruiting | Intrathecal and Systemic Chemotherapy Combined With Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
Condition: childhood rhabdoid tumor of the central nervous system |
| 16. | | Recruiting | Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma
Condition: primary central nervous system lymphoma |
| 17. | | Recruiting | A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Conditions: Glioma; Glioblastoma; Astrocytoma; Oligodendroglioma; Brain Neoplasm |
| 18. | | Recruiting | Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
Conditions: untreated childhood cerebellar astrocytoma; untreated childhood visual pathway and hypothalamic glioma; childhood spinal cord tumors; ... |
| 19. | | Recruiting | Temozolomide for Treatment of Brain Metastases from Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Brain Neoplasms |
| 20. | | Recruiting | Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas
Conditions: adult anaplastic oligodendroglioma; adult anaplastic astrocytoma; adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; ... |
| 21. | | Recruiting | Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 22. | | Recruiting | Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors
Conditions: Brain Neoplasms; Neoplasm Metastasis |
| 23. | | Recruiting | Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
Conditions: intraocular lymphoma; primary central nervous system lymphoma |
| 24. | | Recruiting | Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
Conditions: primary central nervous system lymphoma; intraocular lymphoma |
| 25. | | Recruiting | Rituximab, Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Sodium Thiosulfate and Cytarabine in Treating Patients With Refractory or Recurrent Primary CNS Lymphoma
Conditions: Drug Toxicity; Thrombocytopenia; intraocular lymphoma; primary central nervous system lymphoma |
| 26. | | Recruiting | Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma
Condition: primary central nervous system lymphoma |
| 27. | | Recruiting | Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
Conditions: childhood brain stem glioma; childhood brain tumor; childhood cerebellar astrocytoma; childhood cerebral astrocytoma and malignant glioma; ... |
| 28. | | Recruiting | Autologous Cytotoxic T-Lymphocytes in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Conditions: recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; primary central nervous system lymphoma; ... |
| 29. | | Recruiting | Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Conditions: Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer |
| 30. | | Recruiting | ST1571 to Treat Patients with Recurrent Meningiomas
Condition: Meningioma |
| 31. | | Recruiting | Vaccine Therapy in Treating Patients With Malignant Glioma
Conditions: adult glioblastoma; adult anaplastic astrocytoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 32. | | Recruiting | Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Condition: primary central nervous system lymphoma |
| 33. | | Recruiting | Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity
Condition: Brain Neoplasms |
| 34. | | Recruiting | Cilengitide in Treating Children With Refractory Primary Brain Tumors
Conditions: childhood brain tumor; childhood meningioma; childhood spinal cord tumors |
| 35. | | Recruiting | Intrathecal Mafosfamide
Condition: Malignant Meningeal Neoplasms |
| 36. | | Recruiting | Study of Karenitecin (BNP1350) in patients with brain tumors
Conditions: Brain Neoplasms; Malignant Neoplasms, Brain; Brain Tumors |
| 37. | | Recruiting | Immunotherapy Combined With Chemotherapy Followed by Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
Condition: primary central nervous system lymphoma |
| 38. | | Recruiting | Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Conditions: adult anaplastic astrocytoma; Mixed Gliomas; adult anaplastic oligodendroglioma; recurrent adult brain tumor; adult anaplastic ependymoma |
| 39. | | Recruiting | OSI-774 to Treat Patients with Recurrent Malignant Glioma (Brain Tumor) and Patients with Glioma After Radiation Therapy
Conditions: Glioma; Meningioma |
| 40. | | Recruiting | Study of Neurologic Progression with Motexafin Gadolinium and Radiation Therapy (SMART)
Conditions: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm |
| 41. | | Recruiting | Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 42. | | Not yet recruiting | Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
Condition: recurrent childhood brain tumor |
| 43. | | Recruiting | Gemcitabine in Treating Neoplastic Meningitis in Patients With Leukemia, Lymphoma, or Solid Tumors
Condition: leptomeningeal metastases |
| 44. | | Recruiting | Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
Conditions: childhood brain tumor; childhood meningioma; childhood spinal cord tumors |
| 45. | | Recruiting | Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
Conditions: adult glioblastoma; adult anaplastic astrocytoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma |
| 46. | | Recruiting | Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: adult anaplastic oligodendroglioma; recurrent adult brain tumor; Mixed Gliomas; Adult Oligodendroglioma |
| 47. | | Recruiting | Phase I Study of Gemcitabine to Treat Cancer Spread to the Meninges
Condition: Meningeal Neoplasms |
| 48. | | Recruiting | Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
Conditions: childhood central nervous system germ cell tumor; childhood mature and immature teratomas; recurrent childhood malignant germ cell tumor |
| 49. | | Recruiting | Sirolimus in Treating Patients With Glioblastoma Multiforme
Conditions: recurrent adult brain tumor; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma |
| 50. | | Recruiting | Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Conditions: adult meningioma; recurrent adult brain tumor; grade III meningioma; grade I meningiomna; grade II meningioma |
